Mortgage Blog
MaxCyte shares plunge after Rockville biotech firm sharply lowers 2023 revenue outook
The company is significantly less bullish about revenue growth than it was a few months ago.
Change at the top of Schneider Downs’ wealth management arm
First big leadership change at SDWMA in more than six years; former CEO retains chief compliance officer role.
Doylestown Health unveils rebuilt Children’s Village that was decimated by 2020 tornado
Three years after its childhood education center was heavily damaged by a tornado, Doylestown Health has unveiled its rebuilt $24.1 million Children's Village.
Novant Health cuts 160 jobs across its employee network, including Charlotte
Winston Salem-based Novant Health is laying off 160 employees, just six months after the health-care system cut 50 jobs.
Japanese pharma giant scoops up Seaport biotech for $387.4M
A Japanese pharmaceutical giant is buying a Boston-London biotech for $387.4 million.
Novant Health eliminates 160 mid-, upper-level jobs in largest workforce reduction in almost a decade
Novant Health's largest layoff announcement in nearly a decade comes after the health system reported a 7.6% increase in its labor costs in Q2. Find out what jobs are affected and what it means for the Triad's fourth-largest employer.
Baird agrees to $15M settlement in SEC probe into electronic communications
Robert W. Baird & Co. said it enhanced its compliance procedures and agreed to pay a $15 million settlement to resolve a U.S. Securities and Exchange Commission case alleging the firm violated SEC rules via “widespread and longstanding failures to maintain and preserve electronic communications.”
Former Lennar C-suite executive named among Coral Gables Trust new leadership
The firm has more than $2 billion in assets under management and employs 40 financial professionals.
Women face gap in SBA’s marquee loan program. Some want to change it.
The SBA's primary lending program has a gender gap. Here's where's things stand and what the SBA is doing to address it.
Gene therapy firm to close Lexington research lab amid 114-person layoff
A year after it scored a major win in the form of an FDA approval, a gene therapy firm is retooling things, closing a Lexington research lab amid a 114-person layoff.